36889-15-3 (庆大霉素 B,Gentamicin BDiscontinued, see G360650)

快速询单

结构式：

庆大霉素 BMOL文件

CAS号：

36889-15-3

中文名称：

庆大霉素 B

英文名称：

Gentamicin BDiscontinued, see G360650

分子式：

C₁₉H₃₈N₄O₁₀

分子量：

482.525825977325

API：

Gentamicin

庆大霉素 B(36889-15-3)名称与标识符

名称

中文别名：

倍他米星;庆大霉素 B;

英文别名：

2-(aminomethyl)-6-[4,6-diamino-3-[3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol;BETAMICIN;Betamicin [INN];Betamicina;Betamicina [INN-Spanish];Betamicine [INN-French];Betamicinum [INN-Latin];Gentamicin B;Gentamycin B;reg;Gentamicin BDiscontinued, see G360650;

标识符

InChIKey：

RHRAMPXHWHSKQB-GGEUKFTFSA-N

Inchi：

1S/C19H38N4O10/c1-19(29)5-30-17(13(28)16(19)23-2)32-14-6(21)3-7(22)15(12(14)27)33-18-11(26)10(25)9(24)8(4-20)31-18/h6-18,23-29H,3-5,20-22H2,1-2H3/t6-,7+,8-,9-,10+,11-,12-,13-,14+,15-,16-,17-,18-,19+/m1/s1

SMILES：

O([C@@H]1[C@@H]([C@H]([C@](C)(CO1)O)NC)O)[C@H]1[C@@H](C[C@@H]([C@H]([C@@H]1O)O[C@@H]1[C@@H]([C@H]([C@@H]([C@@H](CN)O1)O)O)O)N)N

庆大霉素 B(36889-15-3)物化性质

实验特性

LogP : -3.50970
PSA : 248.39000

计算特性

精确分子量 : 482.25900

庆大霉素 B(36889-15-3)推荐厂家更多厂家(20)

公司名称	手机号/电话	联系人	QQ	询单
湖北齐飞医药化工有限公司	18702762251 027-59322506	刘经理：18702762251	1438980033	询单
湖北瑞诺医药科技有限公司	13165688766	汪经理	3008058303	询单
湖北诺纳科技有限公司	18995657604 027-59209883	吴经理	2933307129	询单
湖北万得化工有限公司	15827180502 027-59210159	陈丹丹	1148980033	询单
湖北摆渡化学有限公司	18871490324 027-59106051	彭星	1400878899	询单
巨胜化学研究院	18064118002 027-59599240	陈盼	1400838822	询单
天门恒昌化工有限公司	15102714773 027-59322316	雷经理	1178380033	询单
湖北达豪化工有限公司	13986246535	刘紫莹	1400878822	询单
湖北信康医药化工有限公司	13476235517 13476235517	杨彩云	1438280055	询单
湖北实顺生物科技有限公司	15107128801 027-59223025	郑雨晗	1400818899	询单

庆大霉素 B(36889-15-3)相关文献

1. Minor components of aminoglycosides: recent advances in their biosynthesis and therapeutic potential
Yeon Hee Ban,Myoung Chong Song,Je Won Park,Yeo Joon Yoon Nat. Prod. Rep. 2020 37 301
2. Semisynthetic aminoglycoside antibacterials. Part 10. Synthesis of novel 1-N-aminoalkoxycarbonyl and 1-N-aminoalkylcarboxamido derivatives of sisomicin, gentamicin B, gentamicin C1a, and kanamycin A
Alan K. Mallams,James B. Morton,Paul Reichert J. Chem. Soc. Perkin Trans. 1 1981 2186
3. Semisynthetic aminoglycoside antibacterials. Part IV. Synthesis of antibiotic JI-20A, gentamicin B, and related compounds
Max Kugelman,Alan K. Mallams,H. Frederick Vernay J. Chem. Soc. Perkin Trans. 1 1976 1126
4. Semisynthetic aminoglycoside antibacterials. Part 11. Solution conformations of semisynthetic and naturally occurring aminoglycoside antibiotics
Peter J. L. Daniels,Alan K. Mallams,Stuart W. McCombie,James B. Morton,Tatanahalli L. Nagabhushan,Dinanath F. Rane,Paul Reichert,John J. Wright J. Chem. Soc. Perkin Trans. 1 1981 2209
5. Antibiotic susceptibility test under a linear concentration gradient using travelling surface acoustic waves
Yongtaek Im,Seunggyu Kim,Jinsoo Park,Hyung Jin Sung,Jessie S. Jeon Lab Chip 2021 21 3449
6. A C-HCR assembly of branched DNA nanostructures for amplified uracil-DNA glycosylase assays
Jing Wang,Min Pan,Jie Wei,Xiaoqing Liu,Fuan Wang Chem. Commun. 2017 53 12878
7. Reactions of relevance to the chemistry of aminoglycoside antibiotics. Part 10. α-alkylation of primary amines
Derek H. R. Barton,Geneviève Lamotte,William B. Motherwell,Subhash C. Narang J. Chem. Soc. Perkin Trans. 1 1979 2030
8. The synthesis and antibacterial activity study of ruthenium-based metallodrugs with a membrane-disruptive mechanism against Staphylococcus aureus
Yushou Chen,Lianghong Liu,Xuerong Wang,Zhouyuji Liao,Runbin Wang,Yanshi Xiong,Jianxin Cheng,Guijuan Jiang,Jintao Wang,Xiangwen Liao Dalton Trans. 2022 51 14980
9. Aminoglycoside-induced lipotoxicity and its reversal in kidney on chip
Konstantinos Ioannidis,Aaron Cohen,Mohammad Ghosheh,Avner Ehrlich,Amit Fischer,Merav Cohen,Yaakov Nahmias Lab Chip 2022 22 4469
10. Aminoglycoside-induced lipotoxicity and its reversal in kidney on chip
Konstantinos Ioannidis,Aaron Cohen,Mohammad Ghosheh,Avner Ehrlich,Amit Fischer,Merav Cohen,Yaakov Nahmias Lab Chip 2022 22 4469